Impact of comprehensive cardiac rehabilitation program on regression of atherosclerotic plaque and vascular remodeling

Not Applicable

• Conditions: Ischemic heart disease

• Registration Number: JPRN-UMIN000006038
• Lead Sponsor: School of Medicine Juntendo University,Department of Cardiovascular

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-07-25
• Study Completion: 2013-10-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1.Target lesion is bypass graft. 2.Cardiogenic shock 3.Acute exacerbation, cirrhosis, and liver carcinoma of acute hepatitis and chronic hepatitis 4.The renal dysfunction (The serum creatinine value is 2.0mg/dL or more) or the dialytic treatment is being enforced. 5.Patient who judged that examination responsibility doctor is improper as object in present study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change rate and remodeling index of capacity of coronary artery plaque after six months

Secondary Outcome Measures

Name	Time	Method
1.Amount of change of capacity of coronary atherosclerotic plaque 2.Quality change of coronary atherosclerotic plaque 3.Amount of change and change rate of lipid profile 4.Correlation of serum lipid profile value after exercise therapy, the change rate, change of capacity of coronary atherosclerotic plaque rate, quality change, and remodeling index 5.Correlation of value of inflammatory marker after exercise therapy, the change rate, and change of capacity of coronary atherosclerotic plaque rate 6.Correlation of change rate, amount, amount of plague change, and change rate of adeponekuchin 7.Amount of change and change rate of area of coronary atherosclerotic plaque of culprit lesion 8.Minimum blood vessel diameter of culprit lesion, amount of change of percent of stenosis, and change rate 9.Major adverse cardio-cerebro-vascular events 10.All cause death